IL273684A - Variants of beta-glucocerebrosidase for use in treating gaucher disease - Google Patents

Variants of beta-glucocerebrosidase for use in treating gaucher disease

Info

Publication number
IL273684A
IL273684A IL273684A IL27368420A IL273684A IL 273684 A IL273684 A IL 273684A IL 273684 A IL273684 A IL 273684A IL 27368420 A IL27368420 A IL 27368420A IL 273684 A IL273684 A IL 273684A
Authority
IL
Israel
Prior art keywords
glucocerebrosidase
variants
beta
gaucher disease
treating gaucher
Prior art date
Application number
IL273684A
Other languages
Hebrew (he)
Inventor
Silman Israel
Ashani Yaacov
L Sussman Joel
Khersonsky Olga
FLEISHMAN Sarel
Goldenzweig Adi
H Futerman Anthony
POKORNA Sarka
Original Assignee
Yeda Res & Dev
Silman Israel
Ashani Yaacov
L Sussman Joel
Khersonsky Olga
FLEISHMAN Sarel
Goldenzweig Adi
H Futerman Anthony
POKORNA Sarka
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yeda Res & Dev, Silman Israel, Ashani Yaacov, L Sussman Joel, Khersonsky Olga, FLEISHMAN Sarel, Goldenzweig Adi, H Futerman Anthony, POKORNA Sarka filed Critical Yeda Res & Dev
Priority to IL273684A priority Critical patent/IL273684A/en
Priority to JP2022559375A priority patent/JP7830343B2/en
Priority to US17/915,500 priority patent/US20230132790A1/en
Priority to KR1020227037779A priority patent/KR20230003492A/en
Priority to CN202180026117.5A priority patent/CN115348884B/en
Priority to EP21720584.8A priority patent/EP4126226A1/en
Priority to CA3174917A priority patent/CA3174917A1/en
Priority to AU2021245409A priority patent/AU2021245409A1/en
Priority to BR112022019510A priority patent/BR112022019510A2/en
Priority to IL296696A priority patent/IL296696A/en
Priority to PCT/IL2021/050357 priority patent/WO2021199039A1/en
Publication of IL273684A publication Critical patent/IL273684A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/24—Hydrolases (3) acting on glycosyl compounds (3.2)
    • C12N9/2402—Hydrolases (3) acting on glycosyl compounds (3.2) hydrolysing O- and S- glycosyl compounds (3.2.1)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/47—Hydrolases (3) acting on glycosyl compounds (3.2), e.g. cellulases, lactases
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Obesity (AREA)
  • Immunology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Diabetes (AREA)
  • Microbiology (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
IL273684A 2020-03-29 2020-03-29 Variants of beta-glucocerebrosidase for use in treating gaucher disease IL273684A (en)

Priority Applications (11)

Application Number Priority Date Filing Date Title
IL273684A IL273684A (en) 2020-03-29 2020-03-29 Variants of beta-glucocerebrosidase for use in treating gaucher disease
JP2022559375A JP7830343B2 (en) 2020-03-29 2021-03-29 Beta-glucocerebrosidase variant for use in the treatment of Gaucher disease
US17/915,500 US20230132790A1 (en) 2020-03-29 2021-03-29 Variants of beta-glucocerebrosidase for use in treating gaucher disease
KR1020227037779A KR20230003492A (en) 2020-03-29 2021-03-29 Beta-glucocerebrosidase variants for the treatment of Gaucher disease
CN202180026117.5A CN115348884B (en) 2020-03-29 2021-03-29 Beta-glucocerebrosidase variants for the treatment of gaucher's disease
EP21720584.8A EP4126226A1 (en) 2020-03-29 2021-03-29 Variants of beta-glucocerebrosidase for use in treating gaucher disease
CA3174917A CA3174917A1 (en) 2020-03-29 2021-03-29 Variants of beta-glucocerebrosidase for use in treating gaucher disease
AU2021245409A AU2021245409A1 (en) 2020-03-29 2021-03-29 Variants of beta-glucocerebrosidase for use in treating Gaucher Disease
BR112022019510A BR112022019510A2 (en) 2020-03-29 2021-03-29 BETA-GLUCOCEREBROSIDASE VARIANTS FOR USE IN THE TREATMENT OF GAUCHER'S DISEASE
IL296696A IL296696A (en) 2020-03-29 2021-03-29 Variants of beta-glucocerebrosidase for use in treating gaucher disease
PCT/IL2021/050357 WO2021199039A1 (en) 2020-03-29 2021-03-29 Variants of beta-glucocerebrosidase for use in treating gaucher disease

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IL273684A IL273684A (en) 2020-03-29 2020-03-29 Variants of beta-glucocerebrosidase for use in treating gaucher disease

Publications (1)

Publication Number Publication Date
IL273684A true IL273684A (en) 2021-09-30

Family

ID=77989484

Family Applications (1)

Application Number Title Priority Date Filing Date
IL273684A IL273684A (en) 2020-03-29 2020-03-29 Variants of beta-glucocerebrosidase for use in treating gaucher disease

Country Status (1)

Country Link
IL (1) IL273684A (en)

Similar Documents

Publication Publication Date Title
GB2590793B (en) Cannabidiol-C1 for use as a medicament and in the treatment of epilepsy
IL268327A (en) A pharmaceutical composition for use in the treatment or prevention of a c5-related disease and a method for treating or preventing a c5-related disease
GEP201706786B (en) Methods and drug products for treating alzheimer's disease
NZ595789A (en) Pharmaceutical compositions comprising epa and a cardiovascular agent and methods of using the same
EP2467116A4 (en) Method and apparatus for non- invasive aesthetic treatment of skin and sub-dermis.
RU2018145985A (en) ACTIVIN-ACTRII ANTAGONISTS AND THEIR APPLICATION FOR TREATMENT OF BONE TISSUE DISORDERS AND OTHER DISORDERS
CO6660423A2 (en) Compositions and methods to treat gaucher disease
EA201590166A1 (en) COMBINED THERAPY FOR THE TREATMENT OF SCATTERED SCLEROSIS
EP2898064A4 (en) COMPOSITIONS AND METHODS FOR TREATMENT AND PREVENTION OF LESION AND TISSUE DISEASE
IL207559A0 (en) Formulation and method for the prevention and treatment of skeletal manifestation of gaucher's disease
EP2415476A4 (en) COMPOSITION FOR THE PREVENTION AND / OR TREATMENT OF SKIN DISEASES
GB2483419B (en) Formulations for the treatment of deep tissue pain
SG10202002898RA (en) A Pharmaceutical Composition For Use In The Treatment Or Prevention Of A C5-Related Disease And A Method For Treating Or Preventing A C5-Related Disease
ZA202210984B (en) Methods of treating coronavirus disease 2019
SG11202007082PA (en) Composition used for therapeutic treatment of skin disease
IL260078B (en) Therapy for use for the treatment of gaucher's disease
PL4096661T3 (en) Compounds and compositions for use in treating skin disorders
EA201200428A1 (en) COMPOSITION AND METHOD FOR TREATING OBESITY
EP2301561A4 (en) Pharmaceutical composition for treatment of dry eye and/or corneal/conjunctival disorders
IL285776A (en) Compositions useful in treatment of krabbe disease
IL304628A (en) Treatment of skin disorders
IL273684A (en) Variants of beta-glucocerebrosidase for use in treating gaucher disease
ZA201004392B (en) Narcotic emulsion formulations for treatment of surgical pain
IL290726A (en) Use of brazikumab to treat crohn's disease
HK40088089A (en) Variants of beta-glucocerebrosidase for use in treating gaucher disease